对接受胚胎植入前非整倍体遗传学检测的女性中第6天到达桑葚胚阶段的胚胎进行活检的依据
本回顾性队列研究在学术医疗中心纳入763个周期,比较第6天桑葚胚与囊胚的非整倍体率和种植率。各年龄组囊胚非整倍体率均低于致密桑葚胚和空腔桑葚胚(P<0.001);整倍体桑葚胚种植率28.2% vs 整倍体囊胚54.6%(P=0.002),活产率23.1% vs 55.0%(P=0.001)。作者认为<40岁行PGT-A且可用囊胚少者可考虑检测第6天桑葚胚。
要点
- 各年龄组囊胚非整倍体率均低于致密桑葚胚和空腔桑葚胚(P<0.001)。
- ≥40岁女性中致密桑葚胚98.1%、空腔桑葚胚91.6%为非整倍体。
- 整倍体桑葚胚种植率28.2% vs 整倍体囊胚54.6%(P=0.002)。
核心结论
- 第6天桑葚胚应与囊胚一样考虑活检,尤其<40岁行PGT-A且可用囊胚少者。
- 第6天桑葚胚非整倍体率更高、种植率更低,但仍可获得成功妊娠。
研究设计与样本
- 回顾性队列研究,在学术医疗中心进行,共审查1615个周期。
- 纳入第6天活检空腔化或致密桑葚胚的763个周期,采用微阵列比较基因组杂交行PGT-A。
- 比较同一对夫妇来源的桑葚胚与囊胚的非整倍体率和种植情况。
主要发现
- 共活检1260枚桑葚胚和3014枚囊胚。
- <35、35-37、38-39、≥40岁组囊胚非整倍体率分别为40.3%、50.8%、56%、78.3%。
- 同年龄组致密桑葚胚非整倍体率分别为68.7%、75.5%、88.9%、98.1%,空腔桑葚胚分别为57%、66.4%、81%、91.6%(P<0.001)。
- 致密和空腔桑葚胚涉及≥3条染色体的复杂非整倍体率显著高于囊胚(P<0.001)。
- 整倍体桑葚胚种植率28.2% vs 整倍体囊胚54.6%(P=0.002),活产率23.1% vs 55.0%(P=0.001)。
关键数值与推荐
- 各年龄组囊胚非整倍体率均低于致密桑葚胚和空腔桑葚胚(P<0.001)。
- ≥40岁女性中致密桑葚胚98.1%、空腔桑葚胚91.6%为非整倍体。
- 整倍体桑葚胚种植率28.2% vs 整倍体囊胚54.6%(P=0.002)。
- 整倍体桑葚胚活产率23.1% vs 整倍体囊胚55.0%(P=0.001)。
临床怎么用
- 作者认为,<40岁行PGT-A且可用囊胚少者可考虑检测第6天桑葚胚。
- 作者认为,年轻女性行PGT-A时第6天桑葚胚不应丢弃。
局限性
- 桑葚胚阶段活检的潜在缺点是无法区分内细胞团与滋养外胚层细胞来源。
- 本研究中整倍体桑葚胚移植周期的样本量有限。
- 需要更大队列验证本文报告的活产率和自然流产率。
- 需要在不同中心确定研究结果的可重复性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is there a benefit to assessing ploidy in delayed embryos reaching the morula stage on Day 6 of development? SUMMARY ANSWER: Day-6 morulae should be considered for biopsy in women <40 years old undergoing preimplantation genetic testing for aneuploidy (PGT-A) because they are associated with acceptable, albeit reduced, euploidy and implantation rates (IRs). WHAT IS KNOWN ALREADY: Embryo development and morphology have been shown to correlate with aneuploidy and pregnancy rates. During PGT-A cycles, embryos are biopsied if they reach the blastocyst stage by Day 5 or 6, whereas slow-developing embryos are typically deselected and discarded. Determining the viability of slow-developing embryos is particularly relevant for women undergoing PGT-A who have diminished ovarian reserve and a relatively low blastocyst yield. STUDY DESIGN, SIZE, DURATION: This is a retrospective cohort study that was performed at an academic medical center. Patients who underwent IVF with PGT-A were reviewed for inclusion. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 1615 cycles were reviewed. All cycles which involved a biopsy of a cavitating or compacted morula on Day 6 were included (n = 763). PGT-A was performed using array comparative genomic hybridization. The aneuploidy and implantation of morulae were compared to those of blastocysts originating from the same couples. MAIN RESULTS AND THE ROLE OF CHANCE: The study included 763 cycles in which 1260 morulae and 3014 blastocysts were biopsied. Women were divided into four age groups (<35, 35-37, 38-39 and ≥40 years): the prevalence of aneuploidy was consistently lower among blastocysts (40.3, 50.8, 56 and 78.3%, respectively) than among compacted morulae (68.7, 75.5, 88.9 and 98.1%, respectively) and cavitating morulae (57, 66.4, 81 and 91.6%, respectively) throughout the different age groups (P < 0.001). Of note, the majority of compacted morulae (98.1%) and cavitating morulae (91.6%) were aneuploid in women aged ≥40 years. Compacted and cavitating morulae had significantly higher rates of complex aneuploidy, which involves ≥3 chromosomes, compared with blastocysts (P < 0.001). Furthermore, euploid morulae were associated with a significantly lower IR (28.2 versus 54.6%; P = 0.002) and live birth rate (23.1 versus 55.0%; P = 0.001) compared to euploid blastocysts. LIMITATIONS REASONS FOR CAUTION: This study confirms that Day-6 morulae should not be discarded in young women undergoing PGT-A. However, a potential drawback of biopsying embryos at the morula stage is the inability to distinguish between inner cell mass and trophectoderm cell origin. The sample size of euploid morula transfer cycles in this study was limited. Thus, a larger cohort would be beneficial to validate the reassuring live birth and spontaneous abortion rates reported here. Furthermore, the reproducibility of our findings should be determined at different centers. WIDER IMPLICATIONS OF THE FINDINGS: Although Day-6 morulae are associated with higher aneuploidy rates and lower IRs compared to blastocysts, they still yielded successful pregnancies. Therefore, testing Day-6 morulae should be considered, especially for women <40 years old who are undergoing PGT-A with a small cohort of available blastocysts for biopsy. STUDY FUNDING/COMPETING INTEREST(S): The authors have nothing to disclose. They received no specific funding for this work. TRIAL REGISTRATION NUMBER: N/A.
引用
- Irani M, Zaninovic N, Canon C, et al. A rationale for biopsying embryos reaching the morula stage on Day 6 in women undergoing preimplantation genetic testing for aneuploidy. Hum Reprod. 2018. PMID: 29546326. doi:10.1093/humrep/dey053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。